Superficial Cervical Plexus Block for IJCL Pain Management

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

14 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-15

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective randomized trial evaluating the effect of SCPB on reported patient pain following IJCL placement as compared to local infiltrate.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Superficial Cervical Plexus Block for Pacemaker Insertion

NCT01473667

Pacemaker Insertion Regional Block Pain

TERMINATED NA

Ultrasound-guided Precise Superficial Cervical Plexus Block

NCT03695211

Superficial Cervical Plexus Block

UNKNOWN NA

Superficial Cervical Plexus Block for Neck and Shoulder Pain

NCT03210181

Neck Pain Shoulder Pain

COMPLETED NA

Lidocaine Patch for Neck Pain

NCT04378959

Neck Pain Neck Pain, Posterior

COMPLETED NA

Efficacy of Adding Greater Occipital Nerve Block to Trigger Point Injection in Patients With Neck Pain

NCT07058636

Neck Pain Myofacial Pain Syndrome Trigger Point Pain, Myofascial +3 more

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The goal of this study is to determine if SCPBs provide more pain control than local infiltrate of anesthetic for internal jugular venous cannulation. The investigators hypothesis that patients who receive the SCPB will have a lower VAS rating on average than those who receive local infiltration following internal jugular venous cannulation. To test this, the investigators will be approaching eligible patients for inclusion in a research study. If the patients consent, the patients will be randomly assigned the standard of care treatment or the SCPB. The investigators will then ask the patients to rate pain following insertion of the central line. The investigators will also evaluate different aspects of the patient's hospital course to evaluate their outcomes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Superficial Cervical Plexus Block Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participant blinded block randomization of the control local infitrate (Arm 1) and the experimental SCPB (Arm 2).

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Participants will be masked to the anesthesia route selected until after they report their pain scale report. Care provider cannot be blinded in order to complete.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Local Infitrate

Group Type ACTIVE_COMPARATOR

Local Infiltrate

Intervention Type PROCEDURE

Local infiltration location.

SCPB

Group Type EXPERIMENTAL

Superficial Cervical Plexus Block

Intervention Type PROCEDURE

Location of injection for block.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Superficial Cervical Plexus Block

Location of injection for block.

Intervention Type PROCEDURE

Local Infiltrate

Local infiltration location.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who are 18 years and older, and;
* Present to the Akron General Emergency Department (Main) between March 1, 2021 and December 1, 2022, and;
* Require IJVC as a part of their clinical care.

Exclusion Criteria

* Patients who are intubated; or
* Patients who undergo CPR; or
* Patients who have an allergy to lidocaine or bupivacaine; or
* Patients who have a contraindication to receiving a superficial cervical plexus block such as cellulitis over Erb's point or the internal jugular vein, abnormal anatomy, or prior surgery to the area.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No